Equities

Aptahem AB

Aptahem AB

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (SEK)0.03
  • Today's Change-0.001 / -3.23%
  • Shares traded2.19m
  • 1 Year change-83.52%
  • Beta--
Data delayed at least 15 minutes, as of Jun 14 2024.
More ▼
Improved Notifications for Markets Data Alerts
Improved Notifications for Markets Data Alerts
Want push notifications sent directly to your devices for equity price changes and breaking news stories? Let us know here.
 
Existing alertsView our existing alerts
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Aptahem AB is a manufacturer of biological products. The company was founded in 2014 and is located in Malmo, Sweden.

  • Revenue in SEK (TTM)32.00k
  • Net income in SEK-11.32m
  • Incorporated2014
  • Employees--
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Bio Vitos Pharma AB2.61m-12.87m4.47m1.00--1.28--1.71-0.1738-0.17380.02160.10120.09780.05645.492,613,400.00-48.17-31.11-49.96-32.9298.14---492.58-1,026.765.48--0.00--126.97--13.64------
2cureX AB155.00k-30.82m4.58m----0.3343--29.53-1.75-1.750.00880.77770.0048--0.0838---95.89-38.21-108.66-43.48-6,889.68-22,153.06-19,883.23-38,685.30---46.08----72.22---3.52------
QuiaPEG Pharmaceuticals Holding AB0.00-16.52m6.90m8.00--0.4523-----3.51-3.510.000.20470.00-------50.53-95.67-100.54-207.86--262.59---5,002.50---15.340.00------17.75--47.06--
Carbiotix AB (publ)1.70m-14.55m7.71m10.00--0.2868--4.54-0.2357-0.23570.01960.14920.0658--3.43170,052.00-56.32-49.38-62.10-55.50201.79574.69-855.62-1,828.86---45.740.00--259.56-12.04-10.02--13.64--
Eurocine Vaccines AB32.00k-13.93m8.79m3.00------274.62-0.1267-0.12670.0003-0.00140.0072--0.0134---311.00-83.17-462.65-97.89-29,487.50---43,525.00-----818.29--------8.95------
XP Chemistries AB443.13k-7.84m9.25m2.00--0.388--20.87-0.2479-0.24790.00980.25520.01643.2518.68221,565.00-29.04---30.83---1,116.68---1,769.29--4.72--0.00---37.14---1.55------
Stayble Therapeutics AB0.00-23.63m9.26m2.00--0.7195-----0.7935-0.79350.000.40590.00----0.00-153.00-78.64-183.58-95.58------------0.0619------3.22------
Amniotics AB (publ)0.00-30.87m10.93m9.00--0.6977-----0.0374-0.03740.000.00570.00----0.00-112.25-101.09-362.62-149.91--------1.12-16.170.00------35.75------
Diagonal Bio AB23.00k-10.97m12.82m4.00--0.1156--557.41-0.1772-0.17720.00040.27680.0008--2.004,600.00-36.58---47.91---35,765.22---47,713.04--0.2476-27.650.00---88.67--27.75------
Asarina Pharma AB (publ)0.00-12.83m16.98m2.00--10.30-----0.5666-0.56660.000.07280.00----0.00-111.87-61.25-157.85-71.89------------0.3775------3.43------
Aptahem AB32.00k-11.32m17.00m----0.2706--531.10-0.0426-0.04260.00010.11090.0005--0.10---17.54-39.26-18.94-44.194,464.22---35,390.22-----8.440.00-------25.36------
AegirBio AB36.00k-49.38m18.01m14.00------500.22-1.97-1.970.0015-0.34130.0005--0.00652,571.43-67.93---82.25--355.56---137,155.60--0.5183-43.571.40---94.61--83.55------
Lidds AB0.00-30.58m18.70m2.00--1.84-----0.5546-0.55460.000.07460.00----0.00-95.41-46.33-110.09-51.61---1,934.24---3,076.68----0.0812---100.00---9.08------
Data as of Jun 14 2024. Currency figures normalised to Aptahem AB's reporting currency: Swedish Krona SEK
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.